Serum vitamin D levels in children with newly diagnosed and chronic immune thrombocytopenia.

Srđana Čulić, Joško Markić, Davor Petrović, Paško Konjevoda, Jasminka Pavelić

Journal: Seminars in hematology 2017;53 Suppl 1():S67-9

PMID: 27312171

Abstract

The primary objective of the study was to assess the vitamin D (VD) status of patients suffering from ITP. Children from the case cohort (total 21) were recruited from chronic ITP patients (followed as outpatients) and newly diagnosed ITP (prospective study) patients. VD deficiency (values <75 nmol/L) was detected in 11 patients with newly diagnosed ITP, and seven patients with chronic ITP. Only three patients with newly diagnosed, and none with chronic ITP had normal VD values. Newly diagnosed ITP patients had statistically significantly higher values (P <.044) of VD than the patients with chronic type of ITP. Platelets values did not follow VD level. VD deficiency is very common in children with either newly diagnosed or chronic ITP form. Therefore there is a utility supplementing VD in these patients. To investigate the role of VD as an immune modulating drug for patients with ITP, a prospective randomized placebo-controlled trial needs to be performed.

Copyright © 2016 Elsevier Inc. All rights reserved.

Address: Department of Pediatric Hematology, Oncology, Immunology and Medical Genetics, Clinical Hospital Center Split, Medical School, University of Split, Split, Croatia. Electronic address: [email protected].; Department of Pediatric Hematology, Oncology, Immunology and Medical Genetics, Clinical Hospital Center Split, Medical School, University of Split, Split, Croatia.; The Center for Nuclear Magnetic Resonance, Rudjer Bošković Institute, Zagreb, Croatia.; Division of Molecular Medicine, Rudjer Bošković Institute, Zagreb, Croatia.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.